Tennessee Oncology (SCRI) — Nashville, Tennessee

Tennessee Oncology (SCRI) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology (SCRI) has participated in 2 clinical trials.

Therapeutic areas: TNBC - Triple-Negative Breast Cancer, Breast Cancer, Multiple Myeloma.

Sponsors: G1 Therapeutics, Inc., IGM Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology (SCRI)?

Tennessee Oncology (SCRI) has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology (SCRI) conducted?

Tennessee Oncology (SCRI) has 2 clinical trials on record. Their work covers TNBC - Triple-Negative Breast Cancer, Breast Cancer, Multiple Myeloma.

Is Tennessee Oncology (SCRI) accredited by Crixeo Health?

Tennessee Oncology (SCRI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology (SCRI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.